GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (NSE:METROPOLIS) » Definitions » Forward Dividend Yield %

Metropolis Healthcare (NSE:METROPOLIS) Forward Dividend Yield % : 0.00% (As of May. 31, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Forward Dividend Yield %?

As of today (2025-05-31), the Forward Annual Dividend Yield of Metropolis Healthcare is 0.00%.

As of today (2025-05-31), the Trailing Annual Dividend Yield of Metropolis Healthcare is 0.00%.

NSE:METROPOLIS's Forward Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.63
* Ranked among companies with meaningful Forward Dividend Yield % only.

Metropolis Healthcare's Dividends per Share for the three months ended in Mar. 2025 was ₹0.00.

During the past 12 months, Metropolis Healthcare's average Dividends Per Share Growth Rate was -100.00% per year.

During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Metropolis Healthcare was -20.60% per year. The lowest was -20.60% per year. And the median was -20.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Metropolis Healthcare's Forward Dividend Yield %

For the Diagnostics & Research subindustry, Metropolis Healthcare's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metropolis Healthcare's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's Forward Dividend Yield % falls into.


;
;

Metropolis Healthcare Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Metropolis Healthcare  (NSE:METROPOLIS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Metropolis Healthcare Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines